Evidence map›Paper›PMID 33276450›Full record

ArticleVaccines2020

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database.

Guilhem Tournaire, Cécile Conte, Aurore Perrot, Maryse Lapeyre-Mester, Fabien Despas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Guilhem TournaireService de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
Cécile ConteService de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
Aurore PerrotDépartement d'Hématologie et de médecine Interne, Institut Universitaire du Cancer-Oncopole, CHU de Toulouse, 31000 Toulouse, France.ORCID 0000-0003-0131-8689
Maryse Lapeyre-MesterService de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.ORCID 0000-0002-5494-5873
Fabien DespasService de Pharmacologie Médicale et Clinique, CHU de Toulouse, 31000 Toulouse, France.
Université Toulouse III - Paul Sabatier · FRCentre Hospitalier Universitaire de Toulouse · FR

Funding

Agence Nationale de la Recherche ANR-11-PHUC-001
6 · The paper itself

Abstract

purposeInfections are frequent and often result in serious complications in patients with multiple myeloma (MM). Prophylactic vaccination is recommended for influenza virus,

methodsMM patients were selected through the French national health insurance database from 1 January 2010 to 31 December 2015. Patients with a previous history of MM were excluded.

resultsVaccination rates against influenza,

conclusionThe low rates of vaccination indicate the need to improve physician and MM patient adherence and education regarding vaccination.

Indexed as

French national health insurance databaseinfectious diseasesmultiple myelomapharmacoepidemiologyvaccines

Identifiers

PMID33276450
PMCPMC7712872
OpenAlexW3109741772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.